4-(2,3-dimethylbutan-2-yl)morpholine;2,2-dimethyl-1-(2-methylpropyl)piperazine;4-[(2S)-3-methylbutan-2-yl]morpholine;4-[(2R)-3-methylbutan-2-yl]morpholine;4-(3-methylbutan-2-yl)morpholine;(2R)-2-methyl-4-[(2R)-3-methylbutan-2-yl]morpholine;(2S)-2-methyl-4-[(2R)-3-methylbutan-2-yl]morpholine;(2R)-2-methyl-4-[(2S)-3-methylbutan-2-yl]morpholine;(2S)-2-methyl-4-[(2S)-3-methylbutan-2-yl]morpholine;(2R)-2-methyl-4-(3-methylbutan-2-yl)morpholine;(2S)-2-methyl-4-(3-methylbutan-2-yl)morpholine;2-methyl-4-(3-methylbutan-2-yl)morpholine;N-methyl-N-(2-methylpropyl)oxetan-3-amine;4-(2-methylpropyl)morpholine;2,2,4-trimethyl-1-(2-methylpropyl)piperazine

C144H305N17O13 — CID 158618697

IUPAC4-(2,3-dimethylbutan-2-yl)morpholine;2,2-dimethyl-1-(2-methylpropyl)piperazine;4-[(2S)-3-methylbutan-2-yl]morpholine;4-[(2R)-3-methylbutan-2-yl]morpholine;4-(3-methylbutan-2-yl)morpholine;(2R)-2-methyl-4-[(2R)-3-methylbutan-2-yl]morpholine;(2S)-2-methyl-4-[(2R)-3-methylbutan-2-yl]morpholine;(2R)-2-methyl-4-[(2S)-3-methylbutan-2-yl]morpholine;(2S)-2-methyl-4-[(2S)-3-methylbutan-2-yl]morpholine;(2R)-2-methyl-4-(3-methylbutan-2-yl)morpholine;(2S)-2-methyl-4-(3-methylbutan-2-yl)morpholine;2-methyl-4-(3-methylbutan-2-yl)morpholine;N-methyl-N-(2-methylpropyl)oxetan-3-amine;4-(2-methylpropyl)morpholine;2,2,4-trimethyl-1-(2-methylpropyl)piperazine
SMILESCC(C)C(C)(C)N1CCOCC1.CC(C)C(C)N1CCOCC1.CC(C)C(C)N1CCO[C@@H](C)C1.CC(C)C(C)N1CCO[C@H](C)C1.CC(C)CN(C)C1COC1.CC(C)CN1CCN(C)CC1(C)C.CC(C)CN1CCNCC1(C)C.CC(C)CN1CCOCC1.CC(C)[C@@H](C)N1CCOCC1.CC(C)[C@@H](C)N1CCO[C@@H](C)C1.CC(C)[C@@H](C)N1CCO[C@H](C)C1.CC(C)[C@H](C)N1CCOCC1.CC(C)[C@H](C)N1CCO[C@@H](C)C1.CC(C)[C@H](C)N1CCO[C@H](C)C1.CC1CN(C(C)C(C)C)CCO1
InChIInChI=1S/C11H24N2.C10H22N2.8C10H21NO.3C9H19NO.2C8H17NO/c1-10(2)8-13-7-6-12(5)9-11(13,3)4;1-9(2)7-12-6-5-11-8-10(12,3)4;1-9(2)10(3,4)11-5-7-12-8-6-11;7*1-8(2)10(4)11-5-6-12-9(3)7-11;3*1-8(2)9(3)10-4-6-11-7-5-10;1-7(2)4-9(3)8-5-10-6-8;1-8(2)7-9-3-5-10-6-4-9/h10H,6-9H2,1-5H3;9,11H,5-8H2,1-4H3;9H,5-8H2,1-4H3;7*8-10H,5-7H2,1-4H3;3*8-9H,4-7H2,1-3H3;7-8H,4-6H2,1-3H3;8H,3-7H2,1-2H3/t;;;2*9-,10?;2*9-,10+;2*9-,10-;;2*9-;;;/m...101010.10.../s1
InChIKeyHXSIUCUKLGTZCQ-JDCBVMEDSA-N
MW2483.13 g/mol
LogP23.05
Rot. Bonds31

About 4-(2,3-dimethylbutan-2-yl)morpholine;2,2-dimethyl-1-(2-methylpropyl)piperazine;4-[(2S)-3-methylbutan-2-yl]morpholine;4-[(2R)-3-methylbutan-2-yl]morpholine;4-(3-methylbutan-2-yl)morpholine;(2R)-2-methyl-4-[(2R)-3-methylbutan-2-yl]morpholine;(2S)-2-methyl-4-[(2R)-3-methylbutan-2-yl]morpholine;(2R)-2-methyl-4-[(2S)-3-methylbutan-2-yl]morpholine;(2S)-2-methyl-4-[(2S)-3-methylbutan-2-yl]morpholine;(2R)-2-methyl-4-(3-methylbutan-2-yl)morpholine;(2S)-2-methyl-4-(3-methylbutan-2-yl)morpholine;2-methyl-4-(3-methylbutan-2-yl)morpholine;N-methyl-N-(2-methylpropyl)oxetan-3-amine;4-(2-methylpropyl)morpholine;2,2,4-trimethyl-1-(2-methylpropyl)piperazine

4-(2,3-dimethylbutan-2-yl)morpholine;2,2-dimethyl-1-(2-methylpropyl)piperazine;4-[(2S)-3-methylbutan-2-yl]morpholine;4-[(2R)-3-methylbutan-2-yl]morpholine;4-(3-methylbutan-2-yl)morpholine;(2R)-2-methyl-4-[(2R)-3-methylbutan-2-yl]morpholine;(2S)-2-methyl-4-[(2R)-3-methylbutan-2-yl]morpholine;(2R)-2-methyl-4-[(2S)-3-methylbutan-2-yl]morpholine;(2S)-2-methyl-4-[(2S)-3-methylbutan-2-yl]morpholine;(2R)-2-methyl-4-(3-methylbutan-2-yl)morpholine;(2S)-2-methyl-4-(3-methylbutan-2-yl)morpholine;2-methyl-4-(3-methylbutan-2-yl)morpholine;N-methyl-N-(2-methylpropyl)oxetan-3-amine;4-(2-methylpropyl)morpholine;2,2,4-trimethyl-1-(2-methylpropyl)piperazine (PubChem CID 158618697) has the molecular formula C144H305N17O13 and a molecular weight of 2483.13 g/mol. Its IUPAC name is 4-(2,3-dimethylbutan-2-yl)morpholine;2,2-dimethyl-1-(2-methylpropyl)piperazine;4-[(2S)-3-methylbutan-2-yl]morpholine;4-[(2R)-3-methylbutan-2-yl]morpholine;4-(3-methylbutan-2-yl)morpholine;(2R)-2-methyl-4-[(2R)-3-methylbutan-2-yl]morpholine;(2S)-2-methyl-4-[(2R)-3-methylbutan-2-yl]morpholine;(2R)-2-methyl-4-[(2S)-3-methylbutan-2-yl]morpholine;(2S)-2-methyl-4-[(2S)-3-methylbutan-2-yl]morpholine;(2R)-2-methyl-4-(3-methylbutan-2-yl)morpholine;(2S)-2-methyl-4-(3-methylbutan-2-yl)morpholine;2-methyl-4-(3-methylbutan-2-yl)morpholine;N-methyl-N-(2-methylpropyl)oxetan-3-amine;4-(2-methylpropyl)morpholine;2,2,4-trimethyl-1-(2-methylpropyl)piperazine.

Molecular Properties

Compound Name4-(2,3-dimethylbutan-2-yl)morpholine;2,2-dimethyl-1-(2-methylpropyl)piperazine;4-[(2S)-3-methylbutan-2-yl]morpholine;4-[(2R)-3-methylbutan-2-yl]morpholine;4-(3-methylbutan-2-yl)morpholine;(2R)-2-methyl-4-[(2R)-3-methylbutan-2-yl]morpholine;(2S)-2-methyl-4-[(2R)-3-methylbutan-2-yl]morpholine;(2R)-2-methyl-4-[(2S)-3-methylbutan-2-yl]morpholine;(2S)-2-methyl-4-[(2S)-3-methylbutan-2-yl]morpholine;(2R)-2-methyl-4-(3-methylbutan-2-yl)morpholine;(2S)-2-methyl-4-(3-methylbutan-2-yl)morpholine;2-methyl-4-(3-methylbutan-2-yl)morpholine;N-methyl-N-(2-methylpropyl)oxetan-3-amine;4-(2-methylpropyl)morpholine;2,2,4-trimethyl-1-(2-methylpropyl)piperazine
PubChem CID158618697
Molecular FormulaC144H305N17O13
Molecular Weight2483.13 g/mol
Exact Mass2481.37
IUPAC Name4-(2,3-dimethylbutan-2-yl)morpholine;2,2-dimethyl-1-(2-methylpropyl)piperazine;4-[(2S)-3-methylbutan-2-yl]morpholine;4-[(2R)-3-methylbutan-2-yl]morpholine;4-(3-methylbutan-2-yl)morpholine;(2R)-2-methyl-4-[(2R)-3-methylbutan-2-yl]morpholine;(2S)-2-methyl-4-[(2R)-3-methylbutan-2-yl]morpholine;(2R)-2-methyl-4-[(2S)-3-methylbutan-2-yl]morpholine;(2S)-2-methyl-4-[(2S)-3-methylbutan-2-yl]morpholine;(2R)-2-methyl-4-(3-methylbutan-2-yl)morpholine;(2S)-2-methyl-4-(3-methylbutan-2-yl)morpholine;2-methyl-4-(3-methylbutan-2-yl)morpholine;N-methyl-N-(2-methylpropyl)oxetan-3-amine;4-(2-methylpropyl)morpholine;2,2,4-trimethyl-1-(2-methylpropyl)piperazine
SMILESCC(C)C(C)(C)N1CCOCC1.CC(C)C(C)N1CCOCC1.CC(C)C(C)N1CCO[C@@H](C)C1.CC(C)C(C)N1CCO[C@H](C)C1.CC(C)CN(C)C1COC1.CC(C)CN1CCN(C)CC1(C)C.CC(C)CN1CCNCC1(C)C.CC(C)CN1CCOCC1.CC(C)[C@@H](C)N1CCOCC1.CC(C)[C@@H](C)N1CCO[C@@H](C)C1.CC(C)[C@@H](C)N1CCO[C@H](C)C1.CC(C)[C@H](C)N1CCOCC1.CC(C)[C@H](C)N1CCO[C@@H](C)C1.CC(C)[C@H](C)N1CCO[C@H](C)C1.CC1CN(C(C)C(C)C)CCO1
InChIInChI=1S/C11H24N2.C10H22N2.8C10H21NO.3C9H19NO.2C8H17NO/c1-10(2)8-13-7-6-12(5)9-11(13,3)4;1-9(2)7-12-6-5-11-8-10(12,3)4;1-9(2)10(3,4)11-5-7-12-8-6-11;7*1-8(2)10(4)11-5-6-12-9(3)7-11;3*1-8(2)9(3)10-4-6-11-7-5-10;1-7(2)4-9(3)8-5-10-6-8;1-8(2)7-9-3-5-10-6-4-9/h10H,6-9H2,1-5H3;9,11H,5-8H2,1-4H3;9H,5-8H2,1-4H3;7*8-10H,5-7H2,1-4H3;3*8-9H,4-7H2,1-3H3;7-8H,4-6H2,1-3H3;8H,3-7H2,1-2H3/t;;;2*9-,10?;2*9-,10+;2*9-,10-;;2*9-;;;/m...101010.10.../s1
InChIKeyHXSIUCUKLGTZCQ-JDCBVMEDSA-N
XLogP23.05
TPSA183.86 Ų
H-Bond Donors1
H-Bond Acceptors30
Rotatable Bonds31
Heavy Atoms174
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002483.13
LogP ≤ 523.05
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1030

Analyze 4-(2,3-dimethylbutan-2-yl)morpholine;2,2-dimethyl-1-(2-methylpropyl)piperazine;4-[(2S)-3-methylbutan-2-yl]morpholine;4-[(2R)-3-methylbutan-2-yl]morpholine;4-(3-methylbutan-2-yl)morpholine;(2R)-2-methyl-4-[(2R)-3-methylbutan-2-yl]morpholine;(2S)-2-methyl-4-[(2R)-3-methylbutan-2-yl]morpholine;(2R)-2-methyl-4-[(2S)-3-methylbutan-2-yl]morpholine;(2S)-2-methyl-4-[(2S)-3-methylbutan-2-yl]morpholine;(2R)-2-methyl-4-(3-methylbutan-2-yl)morpholine;(2S)-2-methyl-4-(3-methylbutan-2-yl)morpholine;2-methyl-4-(3-methylbutan-2-yl)morpholine;N-methyl-N-(2-methylpropyl)oxetan-3-amine;4-(2-methylpropyl)morpholine;2,2,4-trimethyl-1-(2-methylpropyl)piperazine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 4-(2,3-dimethylbutan-2-yl)morpholine;2,2-dimethyl-1-(2-methylpropyl)piperazine;4-[(2S)-3-methylbutan-2-yl]morpholine;4-[(2R)-3-methylbutan-2-yl]morpholine;4-(3-methylbutan-2-yl)morpholine;(2R)-2-methyl-4-[(2R)-3-methylbutan-2-yl]morpholine;(2S)-2-methyl-4-[(2R)-3-methylbutan-2-yl]morpholine;(2R)-2-methyl-4-[(2S)-3-methylbutan-2-yl]morpholine;(2S)-2-methyl-4-[(2S)-3-methylbutan-2-yl]morpholine;(2R)-2-methyl-4-(3-methylbutan-2-yl)morpholine;(2S)-2-methyl-4-(3-methylbutan-2-yl)morpholine;2-methyl-4-(3-methylbutan-2-yl)morpholine;N-methyl-N-(2-methylpropyl)oxetan-3-amine;4-(2-methylpropyl)morpholine;2,2,4-trimethyl-1-(2-methylpropyl)piperazine?
The IUPAC name of 4-(2,3-dimethylbutan-2-yl)morpholine;2,2-dimethyl-1-(2-methylpropyl)piperazine;4-[(2S)-3-methylbutan-2-yl]morpholine;4-[(2R)-3-methylbutan-2-yl]morpholine;4-(3-methylbutan-2-yl)morpholine;(2R)-2-methyl-4-[(2R)-3-methylbutan-2-yl]morpholine;(2S)-2-methyl-4-[(2R)-3-methylbutan-2-yl]morpholine;(2R)-2-methyl-4-[(2S)-3-methylbutan-2-yl]morpholine;(2S)-2-methyl-4-[(2S)-3-methylbutan-2-yl]morpholine;(2R)-2-methyl-4-(3-methylbutan-2-yl)morpholine;(2S)-2-methyl-4-(3-methylbutan-2-yl)morpholine;2-methyl-4-(3-methylbutan-2-yl)morpholine;N-methyl-N-(2-methylpropyl)oxetan-3-amine;4-(2-methylpropyl)morpholine;2,2,4-trimethyl-1-(2-methylpropyl)piperazine (CID 158618697) is 4-(2,3-dimethylbutan-2-yl)morpholine;2,2-dimethyl-1-(2-methylpropyl)piperazine;4-[(2S)-3-methylbutan-2-yl]morpholine;4-[(2R)-3-methylbutan-2-yl]morpholine;4-(3-methylbutan-2-yl)morpholine;(2R)-2-methyl-4-[(2R)-3-methylbutan-2-yl]morpholine;(2S)-2-methyl-4-[(2R)-3-methylbutan-2-yl]morpholine;(2R)-2-methyl-4-[(2S)-3-methylbutan-2-yl]morpholine;(2S)-2-methyl-4-[(2S)-3-methylbutan-2-yl]morpholine;(2R)-2-methyl-4-(3-methylbutan-2-yl)morpholine;(2S)-2-methyl-4-(3-methylbutan-2-yl)morpholine;2-methyl-4-(3-methylbutan-2-yl)morpholine;N-methyl-N-(2-methylpropyl)oxetan-3-amine;4-(2-methylpropyl)morpholine;2,2,4-trimethyl-1-(2-methylpropyl)piperazine.
What is the SMILES notation for 4-(2,3-dimethylbutan-2-yl)morpholine;2,2-dimethyl-1-(2-methylpropyl)piperazine;4-[(2S)-3-methylbutan-2-yl]morpholine;4-[(2R)-3-methylbutan-2-yl]morpholine;4-(3-methylbutan-2-yl)morpholine;(2R)-2-methyl-4-[(2R)-3-methylbutan-2-yl]morpholine;(2S)-2-methyl-4-[(2R)-3-methylbutan-2-yl]morpholine;(2R)-2-methyl-4-[(2S)-3-methylbutan-2-yl]morpholine;(2S)-2-methyl-4-[(2S)-3-methylbutan-2-yl]morpholine;(2R)-2-methyl-4-(3-methylbutan-2-yl)morpholine;(2S)-2-methyl-4-(3-methylbutan-2-yl)morpholine;2-methyl-4-(3-methylbutan-2-yl)morpholine;N-methyl-N-(2-methylpropyl)oxetan-3-amine;4-(2-methylpropyl)morpholine;2,2,4-trimethyl-1-(2-methylpropyl)piperazine?
The canonical SMILES for 4-(2,3-dimethylbutan-2-yl)morpholine;2,2-dimethyl-1-(2-methylpropyl)piperazine;4-[(2S)-3-methylbutan-2-yl]morpholine;4-[(2R)-3-methylbutan-2-yl]morpholine;4-(3-methylbutan-2-yl)morpholine;(2R)-2-methyl-4-[(2R)-3-methylbutan-2-yl]morpholine;(2S)-2-methyl-4-[(2R)-3-methylbutan-2-yl]morpholine;(2R)-2-methyl-4-[(2S)-3-methylbutan-2-yl]morpholine;(2S)-2-methyl-4-[(2S)-3-methylbutan-2-yl]morpholine;(2R)-2-methyl-4-(3-methylbutan-2-yl)morpholine;(2S)-2-methyl-4-(3-methylbutan-2-yl)morpholine;2-methyl-4-(3-methylbutan-2-yl)morpholine;N-methyl-N-(2-methylpropyl)oxetan-3-amine;4-(2-methylpropyl)morpholine;2,2,4-trimethyl-1-(2-methylpropyl)piperazine is CC(C)C(C)(C)N1CCOCC1.CC(C)C(C)N1CCOCC1.CC(C)C(C)N1CCO[C@@H](C)C1.CC(C)C(C)N1CCO[C@H](C)C1.CC(C)CN(C)C1COC1.CC(C)CN1CCN(C)CC1(C)C.CC(C)CN1CCNCC1(C)C.CC(C)CN1CCOCC1.CC(C)[C@@H](C)N1CCOCC1.CC(C)[C@@H](C)N1CCO[C@@H](C)C1.CC(C)[C@@H](C)N1CCO[C@H](C)C1.CC(C)[C@H](C)N1CCOCC1.CC(C)[C@H](C)N1CCO[C@@H](C)C1.CC(C)[C@H](C)N1CCO[C@H](C)C1.CC1CN(C(C)C(C)C)CCO1.
What is the InChIKey of 4-(2,3-dimethylbutan-2-yl)morpholine;2,2-dimethyl-1-(2-methylpropyl)piperazine;4-[(2S)-3-methylbutan-2-yl]morpholine;4-[(2R)-3-methylbutan-2-yl]morpholine;4-(3-methylbutan-2-yl)morpholine;(2R)-2-methyl-4-[(2R)-3-methylbutan-2-yl]morpholine;(2S)-2-methyl-4-[(2R)-3-methylbutan-2-yl]morpholine;(2R)-2-methyl-4-[(2S)-3-methylbutan-2-yl]morpholine;(2S)-2-methyl-4-[(2S)-3-methylbutan-2-yl]morpholine;(2R)-2-methyl-4-(3-methylbutan-2-yl)morpholine;(2S)-2-methyl-4-(3-methylbutan-2-yl)morpholine;2-methyl-4-(3-methylbutan-2-yl)morpholine;N-methyl-N-(2-methylpropyl)oxetan-3-amine;4-(2-methylpropyl)morpholine;2,2,4-trimethyl-1-(2-methylpropyl)piperazine?
The InChIKey is HXSIUCUKLGTZCQ-JDCBVMEDSA-N. The full InChI is InChI=1S/C11H24N2.C10H22N2.8C10H21NO.3C9H19NO.2C8H17NO/c1-10(2)8-13-7-6-12(5)9-11(13,3)4;1-9(2)7-12-6-5-11-8-10(12,3)4;1-9(2)10(3,4)11-5-7-12-8-6-11;7*1-8(2)10(4)11-5-6-12-9(3)7-11;3*1-8(2)9(3)10-4-6-11-7-5-10;1-7(2)4-9(3)8-5-10-6-8;1-8(2)7-9-3-5-10-6-4-9/h10H,6-9H2,1-5H3;9,11H,5-8H2,1-4H3;9H,5-8H2,1-4H3;7*8-10H,5-7H2,1-4H3;3*8-9H,4-7H2,1-3H3;7-8H,4-6H2,1-3H3;8H,3-7H2,1-2H3/t;;;2*9-,10?;2*9-,10+;2*9-,10-;;2*9-;;;/m...101010.10.../s1.
What are the key properties of 4-(2,3-dimethylbutan-2-yl)morpholine;2,2-dimethyl-1-(2-methylpropyl)piperazine;4-[(2S)-3-methylbutan-2-yl]morpholine;4-[(2R)-3-methylbutan-2-yl]morpholine;4-(3-methylbutan-2-yl)morpholine;(2R)-2-methyl-4-[(2R)-3-methylbutan-2-yl]morpholine;(2S)-2-methyl-4-[(2R)-3-methylbutan-2-yl]morpholine;(2R)-2-methyl-4-[(2S)-3-methylbutan-2-yl]morpholine;(2S)-2-methyl-4-[(2S)-3-methylbutan-2-yl]morpholine;(2R)-2-methyl-4-(3-methylbutan-2-yl)morpholine;(2S)-2-methyl-4-(3-methylbutan-2-yl)morpholine;2-methyl-4-(3-methylbutan-2-yl)morpholine;N-methyl-N-(2-methylpropyl)oxetan-3-amine;4-(2-methylpropyl)morpholine;2,2,4-trimethyl-1-(2-methylpropyl)piperazine?
4-(2,3-dimethylbutan-2-yl)morpholine;2,2-dimethyl-1-(2-methylpropyl)piperazine;4-[(2S)-3-methylbutan-2-yl]morpholine;4-[(2R)-3-methylbutan-2-yl]morpholine;4-(3-methylbutan-2-yl)morpholine;(2R)-2-methyl-4-[(2R)-3-methylbutan-2-yl]morpholine;(2S)-2-methyl-4-[(2R)-3-methylbutan-2-yl]morpholine;(2R)-2-methyl-4-[(2S)-3-methylbutan-2-yl]morpholine;(2S)-2-methyl-4-[(2S)-3-methylbutan-2-yl]morpholine;(2R)-2-methyl-4-(3-methylbutan-2-yl)morpholine;(2S)-2-methyl-4-(3-methylbutan-2-yl)morpholine;2-methyl-4-(3-methylbutan-2-yl)morpholine;N-methyl-N-(2-methylpropyl)oxetan-3-amine;4-(2-methylpropyl)morpholine;2,2,4-trimethyl-1-(2-methylpropyl)piperazine has a molecular weight of 2483.13 g/mol, XLogP of 23.05, 31 rotatable bonds, 1 hydrogen bond donors, and 30 hydrogen bond acceptors.
Where does this data come from?
All data for 4-(2,3-dimethylbutan-2-yl)morpholine;2,2-dimethyl-1-(2-methylpropyl)piperazine;4-[(2S)-3-methylbutan-2-yl]morpholine;4-[(2R)-3-methylbutan-2-yl]morpholine;4-(3-methylbutan-2-yl)morpholine;(2R)-2-methyl-4-[(2R)-3-methylbutan-2-yl]morpholine;(2S)-2-methyl-4-[(2R)-3-methylbutan-2-yl]morpholine;(2R)-2-methyl-4-[(2S)-3-methylbutan-2-yl]morpholine;(2S)-2-methyl-4-[(2S)-3-methylbutan-2-yl]morpholine;(2R)-2-methyl-4-(3-methylbutan-2-yl)morpholine;(2S)-2-methyl-4-(3-methylbutan-2-yl)morpholine;2-methyl-4-(3-methylbutan-2-yl)morpholine;N-methyl-N-(2-methylpropyl)oxetan-3-amine;4-(2-methylpropyl)morpholine;2,2,4-trimethyl-1-(2-methylpropyl)piperazine is sourced from PubChem (CID 158618697), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).